 |
 |
 |
 |
n-3 PUFA Effects on Periodontitis in Humans
D.R. DAWSON, III1, S.S. KIRAKODU2, K. NOVAK2, J. EBERSOLE2, and M.J. NOVAK2, 1University of Kentucky College of Dentistry, Lexington, USA, 2University of Kentucky, Lexington, USA | Dietary n-3 polyunsaturated fatty acids (n-3 PUFA) have
shown an immunomodulating effect on host responses in chronic inflammation. However,
there is limited information regarding n-3 PUFA as an adjunctive treatment of
chronic periodontitis. Objective: This study evaluated changes in clinical
parameters of periodontitis and the levels of three periodontal pathogens in patients
treated with n-3 PUFA. Methods: A randomized double-blind placebo
controlled study has enrolled 56 subjects into four groups: Grp1) oral hygiene
instruction (OHI) +placebo, Grp2) OHI + n-3 PUFA, Grp3) scaling/root planing (S/RP)
+placebo, Grp4) S/RP + n-3 PUFA. Clinical evaluation and microbiologic samples
from diseased and healthy sites were collected at baseline, 8, 16 and 28 weeks
and were processed by qPCR. A universal primer was used to estimate total
microbial counts and species-specific primers were used to quantify P.
gingivalis, T. denticola, T. forsythia. Results: SRP treatment
significantly improved the clinical parameters of bleeding and tissue
destruction (PD, AL). PUFA alone had a minimal impact on destruction, but did
appear to lower the overall level of bleeding. The combination treatment also
significantly improved periodontal health although there was no obvious
synergism of S/RP and PUFA. The pathogens were initially approximately 15% of
the total bacteria in diseased sites. Grp1 and Grp2 showed no effect on the
total bacteria or individual species. In contrast, Grp3 demonstrated a
significant decrease in their overall proportions (~4%), as well as significant
decreases in each of the three species. Finally, addition of PUFA (Grp4) did
not appear to provide any additional impact on the pathogenic species in the
plaque. Conclusions: The initial outcomes suggest that dietary n-3
PUFA may provide some adjunctive benefit to S/RP in treating periodontitis;
however, this did not appear to be via alterations of the microbial composition
of diseased sites. Supported by P20 RR020145 from the NCRR.
|
Seq #12 - Periodontal Therapy: Antimicrobials and Immune Modulators 3:15 PM-4:45 PM, Wednesday, April 2, 2008 Hilton Anatole Hotel Topaz |
Back to the Periodontal Research - Therapy Program
|
|